COVID-19 and Subsequent Development of Pancytopenia With Concurrent Disseminated Intravascular Coagulation

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Jan 25

PMID 36694508

Authors

Michael D Dube

Sumina Sapkota

Khushboo Lakhatariya

Anthony Russo

Affiliations

Soon will be listed here.

Abstract

Complications resulting from coronavirus disease 2019 (COVID-19) sequelae have been well documented. These include blood conditions such as lymphopenia, thrombocytopenia, and hypercoagulability. Less common problems that may arise are disseminated intravascular coagulation (DIC), immune thrombocytopenic purpura (ITP), and pancytopenia. Furthermore, the majority of COVID-19 patients to develop pancytopenia have been immunosuppressed. We present a case of a previously immunocompetent patient who subsequently developed pancytopenia, DIC, as well as symptoms of ITP one month after being diagnosed with COVID-19.

References

Ufuk F, Bulgurcu E, Sari T . COVID-19-associated pancytopenia and typhlitis. Am J Emerg Med. 2021; 45:685.e1-685.e3. PMC: 7831735. DOI: 10.1016/j.ajem.2020.12.049. View

Deruelle E, Ben Hadj Salem O, Sep Hieng S, Pichereau C, Outin H, Jamme M . Immune thrombocytopenia in a patient with COVID-19. Int J Hematol. 2020; 112(6):883-888. PMC: 7365304. DOI: 10.1007/s12185-020-02943-5. View

Singh B, Ayad S, Kaur P, Kumar V, Gupta S, Maroules M . COVID-19-Induced Pancytopenia in a Major Molecular Response CML Patient on Dasatinib: A Case Report and Review of the Literature. Eur J Case Rep Intern Med. 2021; 8(1):002233. PMC: 7875585. DOI: 10.12890/2021_002233. View

Zhao Y, He J, Wang J, Li W, Xu M, Yu X . Development of pancytopenia in a patient with COVID-19. J Med Virol. 2020; 93(3):1219-1220. PMC: 7537507. DOI: 10.1002/jmv.26566. View

Wang Z, Gao X, Miao H, Ma X, Ding R . Understanding COVID-19-associated coagulopathy: From PIC to SIC or DIC. J Intensive Med. 2023; 1(1):35-41. PMC: 7997848. DOI: 10.1016/j.jointm.2021.03.002. View

Merrill J, Erkan D, Winakur J, James J . Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020; 16(10):581-589. PMC: 7391481. DOI: 10.1038/s41584-020-0474-5. View

Bridwell R, Inman B, Birdsong S, Goss S, Long B . A coronavirus disease-2019 induced pancytopenia. Am J Emerg Med. 2021; 47:324.e1-324.e3. PMC: 7902224. DOI: 10.1016/j.ajem.2021.02.043. View

Davoodian A, Umeh C, Novatcheva E, Sassi G, Ahaneku H, Kundu A . Severe Immune Thrombocytopenia Post-COVID-19: A Case Report. Cureus. 2021; 13(11):e19544. PMC: 8668258. DOI: 10.7759/cureus.19544. View

Barranco-Trabi J, Minns R, Akter R, Park K, Babb S, Masel J . Case Report: COVID Associated Pancytopenia Unmasking Previously Undiagnosed Pernicious Anemia. Am J Trop Med Hyg. 2022; . PMC: 9294700. DOI: 10.4269/ajtmh.21-1194. View

10.

Li M, Li L, Zhang Y, Wang X . Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020; 9(1):45. PMC: 7186534. DOI: 10.1186/s40249-020-00662-x. View

11.

Rahi M, Jindal V, Reyes S, Gunasekaran K, Gupta R, Jaiyesimi I . Hematologic disorders associated with COVID-19: a review. Ann Hematol. 2021; 100(2):309-320. PMC: 7789889. DOI: 10.1007/s00277-020-04366-y. View

12.

Sharma N, Shukla R, Warrier R, Kumar K, Singh N, Ghose S . Pancytopenia Secondary to SARS-CoV-2 Infection-a Case Report. SN Compr Clin Med. 2022; 4(1):31. PMC: 8743232. DOI: 10.1007/s42399-021-01085-x. View

13.

Zulfiqar A, Lorenzo-Villalba N, Hassler P, Andres E . Immune Thrombocytopenic Purpura in a Patient with Covid-19. N Engl J Med. 2020; 382(18):e43. PMC: 7179995. DOI: 10.1056/NEJMc2010472. View